-- Investment forms part of the company's ongoing commitment to leading technologies and solutions that reinforce and complement its core businesses
-- Transaction will offer synergies to Grifols' Bio Supplies Division and its Diagnostic Division's leading transfusion medicine business
PR Newswire
BARCELONA, Spain, July 23, 2020